Clinical trials of immune suppressor drugs in Canada also yielded bad results-- several subjects were infected with tuberculosis. Activation of TB is a prominent warning on immune suppressor drugs yet the subjects had not received any specific tests for tuberculosis for their study participation.
The label on Humira says patients "are at increased risk for developing serious infections that may lead to hospitalization or death," that include "Invasive fungal infections, including histoplasmosis, coccidioidomycosi," and "Bacterial, viral and other infections due to opportunistic pathogens, including Legionella and Listeria."
It is often said you don't want to watch how laws or sausage is made. Clearly "new drugs" needs to be added to the list.
(Article changed on March 21, 2015 at 17:14)